frontline treatment of transplant-ineligible mm: a changing landscape
Published 5 years ago • 73 plays • Length 4:59Download video MP4
Download video MP3
Similar videos
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
4:23
the changing role of chemotherapy in the treatment of various subtypes of nhl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:25
root zx3 operation quick guide - retreatment with a bony defect
-
3:29
fue hair transplant repair (705 grafts) by dr juan couto - fuexpert clinic, madrid, spain
-
12:05
how to clean/change biobase hematology valves
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
4:34
modulation of the microbiota for the treatment of gvhd
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
5:18
upfront treatment in transplant candidates
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
5:02
advances in the treatment of all: how far have we come?
-
1:45
how should we utilizing molecular data to improve all treatment?
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml